0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Treatment of Calcinosis Universalis with Chelating Agent

CHESTER W. FINK, M.D.; JOHN BAUM, M.D.
Am J Dis Child. 1963;105(4):390-392. doi:10.1001/archpedi.1963.02080040392012.
Text Size: A A A
Published online

Because of the reported favorable effects of chelating agents in calcium deposition diseases,1-5 we are reporting our experience in the treatment of 3 cases of calcinosis universalis presumed secondary to dermatomyositis. The regimen chosen was used by many authors effectively in scleroderma 1-4 and in one reported case of calcinosis universalis.5

Therapeutic Regimen.—Edetate (disodium ethylenediaminetetraacetic acid [EDTA]) supplied as Endrate by Abbott Laboratories was used. Each child received 50 mg. per kilogram in 5% dextrose daily for 5 days. This was followed by a 2-day rest period and the cycle repeated twice for a total of 15 days of therapy. Range of motion at the major joints was measured immediately prior to and immediately after therapy as well as at a subsequent follow-up. No physical therapy was given while the patients were hospitalized, but they were allowed full activity. They were placed on a low-calcium diet during

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();